Armistice Capital Master Fund Ltd., Director, 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 1,136,097 shares at $1.04 ($1.1M) on 2022-01-07, disclosed to the SEC on 2022-01-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.04 | 137,900 | $143K | 12.7% |
| 2 | $0.99 | 491,097 | $486K | 43.0% |
| 3 | $0.99 | 491,097 | $486K | 43.0% |
| 4 | $0.96 | 16,003 | $15K | 1.4% |
| Total | $1.00 avg | 1,136,097 | $1.1M | 100% |
| Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |
| RSLS | BUY | 2020-11-12 | $9K | — | Filing → |